PMID: 9658204Jul 11, 1998Paper

Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation

Molecular Pharmacology
W S EdgemondW B Campbell

Abstract

Arachidonylethanolamide (AEA), the putative endogenous ligand of the cannabinoid receptor, has been shown to be a substrate for lipoxygenase enzymes in vitro. One goal of this study was to determine whether lipoxygenase-rich cells metabolize AEA. [14C]AEA was converted by human polymorphonuclear leukocytes (PMNs) to two major metabolites that comigrated with synthetic 12(S)- and 15(S)-hydroxy-arachidonylethanolamide (HAEA). Human platelets convert [14C]AEA to 12(S)-HAEA. 12(S)-HAEA binds to both CB1 and CB2 receptors with approximately the same affinity as AEA. 12(R)-HAEA, which is not produced by PMNs, has 2-fold lower affinity for the CB1 receptor and 10-fold lower affinity for the CB2 receptor than 12(S)-HAEA. 15-HAEA has a lower affinity than AEA for both receptors, with Ki values of 738 and >1000 nM for CB1 and CB2 receptors, respectively. The addition of a hydroxyl group at C20 of AEA resulted in a ligand with the same affinity for the CB1 receptor but a 4-fold lower affinity for the CB2 receptor than AEA. 12(S)-HAEA and 15-HAEA are poor substrates for AEA amidohydrolase and do not bind to the AEA uptake carrier. In conclusion, the addition of a hydroxyl group at C12 of the arachidonate backbone of AEA does not affect bin...Continue Reading

References

May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P Borgeat, B Samuelsson
Oct 30, 1992·Biochimica Et Biophysica Acta·S Yamamoto
Dec 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·D J Fretland, S W Djuric
Jul 31, 1985·Biochemical and Biophysical Research Communications·G JungA Nakao
Oct 4, 1995·Biochemical and Biophysical Research Communications·T SugiuraK Waku
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·L FacciA Leon
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·S K DasS K Dey
Feb 9, 1993·European Journal of Pharmacology·E Fride, R Mechoulam
Nov 14, 1997·Journal of Medicinal Chemistry·H H SeltzmanB R Martin
Nov 14, 1997·FEBS Letters·M van der SteltJ F Vliegenthart
Dec 6, 1997·European Journal of Pharmacology·A CalignanoD Piomelli

❮ Previous
Next ❯

Citations

Oct 1, 2003·British Journal of Pharmacology·Ruth A Ross
Feb 3, 2007·The Journal of Pharmacology and Experimental Therapeutics·Natasha T SniderPaul F Hollenberg
Sep 19, 2007·British Journal of Pharmacology·S P H Alexander, D A Kendall
Jul 2, 2010·British Journal of Pharmacology·L E StaniaszekV Chapman
Nov 15, 2012·Proceedings of the National Academy of Sciences of the United States of America·Fabricio A PamplonaReinaldo N Takahashi
Dec 10, 2017·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Salvador SierraJudith Navarro-Otano
Mar 10, 2004·Biological Reviews of the Cambridge Philosophical Society·C Robin Hiley, William R Ford
Jan 28, 2004·British Journal of Pharmacology·Luciano De PetrocellisVincenzo Di Marzo
Jul 2, 2010·British Journal of Pharmacology·Linda K VaughnCecilia J Hillard
Jun 10, 2011·Journal of Psychopharmacology·F A Pamplona, R N Takahashi
Jun 8, 2013·Reproduction : the Official Journal of the Society for the Study of Fertility·Hsiu-Wen ChanMurray D Mitchell
Aug 16, 2003·European Journal of Biochemistry·Lambrini FasiaAthanassia Siafaka-Kapadai
Dec 18, 2008·Nature Chemical Biology·Lawrence J Marnett
Aug 2, 2005·The Journal of Pharmacology and Experimental Therapeutics·Birgit Kraft, Hans G Kress
Dec 27, 2013·International Journal of Endocrinology·Thangesweran AyakannuJustin C Konje
Mar 12, 2009·Journal of Cardiovascular Pharmacology·C Robin Hiley
May 11, 2015·Cellular and Molecular Life Sciences : CMLS·Valeria GasperiMaria Valeria Catani
Feb 4, 2016·Neural Plasticity·Jantana Keereetaweep, Kent D Chapman
Jun 15, 2017·Frontiers in Molecular Neuroscience·Mauro Maccarrone
May 7, 2004·European Journal of Biochemistry·Mario Van Der Stelt, Vincenzo Di Marzo
Feb 1, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·François ChouinardNicolas Flamand
Jun 29, 2010·Journal of Biomolecular Screening·Märta DahlströmPontus K A Forsell
Jul 10, 2007·British Journal of Pharmacology·C J Fowler
Aug 21, 2007·British Journal of Pharmacology·M D Randall
Sep 2, 2020·Annual Review of Pharmacology and Toxicology·Noëlle van EgmondMario van der Stelt
Feb 12, 1999·Neurobiology of Disease·V Di Marzo, D G Deutsch
Aug 1, 2002·Life Sciences·Osama M H HabayebJustin C Konje
Aug 26, 1999·Life Sciences·B R MartinR K Razdan
May 13, 2021·Journal of Cell Communication and Signaling·Roger Gregory Biringer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.